鉤端螺旋體病市場：依藥物、診斷、給藥途徑、通路及地區分類

據估計，2026年鉤端螺旋體病市值為5.897億美元，預計2033年將達到8.867億美元。預計從2026年到2033年，其複合年成長率將達到6.0%。

鉤端螺旋體病是由一種稱為鉤端螺旋體的細菌引起的。鉤端螺旋體病是一種可感染人類和動物的疾病。感染可表現出多種症狀，其中一些症狀可能與其他疾病的症狀混淆。大多數鉤端螺旋體病病例發生在熱帶地區。在美國，每年通常報告100至150例人類病例。在戶外工作、在動物附近工作或從事與淡水相關的活動的人更容易感染。接觸鉤端螺旋體可能導致嚴重的症狀，也可能沒有任何症狀。鉤端螺旋體病可引起類似流感的症狀，例如突發高燒、畏寒、頭痛、劇烈身體疼痛和疲勞。在10%的病例中，可能會出現影響肝臟、腎臟或神經系統的更嚴重的併發症。鉤端螺旋體病可以使用醫生處方的特定抗生素來治療。感染者應盡快就醫。

市場動態

預計在預測期內，專注於研發鉤端螺旋體病疫苗的研究機構將加強研發力度，並推動全球鉤端螺旋體病市場成長。例如，2022年7月6日，美國耶魯大學醫學院宣布，正致力於研發針對致命的利伯蒂納鉤端螺旋體（Leptospira libertina）的疫苗。下一步是將實驗室研究成果轉化為疫苗，該疫苗將首先用於動物試驗，然後再用於人體試驗。

本研究的主要特點：

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數介紹了全球鉤端螺旋體病市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球鉤端螺旋體病市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
• 相關人員可以透過分析全球鉤端螺旋體病市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 監管指南
• 產品發布
• 主要進展
• PEST分析
• 監管趨勢
• 併購

第4章 全球鉤端螺旋體病市場：依藥物分類，2021-2033年

• 概述
• 阿莫西林
• 阿奇黴素
• 頭孢克肟
• 多西環素
• 其他藥物（頭孢曲松、青黴素等）

第5章 全球鉤端螺旋體病市場：依診斷方法分類，2021-2033年

• 概述
• 血液常規檢查（CBC）
• 肌酸激酶
• 肝臟酵素
• 尿液檢查
• 其他（腰椎穿刺、顯微鏡下凝集試驗等）

第6章 全球鉤端螺旋體病市場：依給藥途徑分類，2021-2033年

• 概述
• 口服
• 腸外
• 靜脈

第7章 全球鉤端螺旋體病市場：依通路分類，2021-2033年

• 概述
• 醫院藥房
• 零售藥房
• 網路藥房

第8章 全球鉤端螺旋體病市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第9章 競爭情勢

• USAntibiotics
• Reddy's Laboratories Ltd.
• Century Pharmaceuticals Ltd.
  • Company Highlight
• Mayne Pharma Group Limited
• Sun Pharmaceutical Industries, Inc.
• Ralington Pharma
• F. Hoffmann-La Roche Ltd
• Pfizer Inc.
• Sandoz International GmbH
• ISKON REMEDIES & GMT
• Haustus Biotech Pvt. Ltd.
• Aden Healthcare

第10章

• 調查方法
• 關於本公司

Leptospirosis Market is estimated to be valued at USD 589.7 Mn in 2026 and is expected to reach USD 886.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033.

The bacterium that causes Leptospirosis is called leptospira. Leptospirosis is a disease that can affect humans and animals. People may experience a variety of symptoms from it, some of which may be mistaken for those of other disorders. Most cases of leptospirosis occur in tropical regions. In the U.S., 100 to 150 cases of human sickness are often documented each year. People who work outside, around animals, or who engage in freshwater activities could be more susceptible to infection. Leptospirosis exposure can cause severe symptoms or sometimes no symptoms at all in a person. Flu-like symptoms, including rapid fever, chills, headache, excruciating body aches, and weariness, can be brought on by leptospirosis. A more serious sickness affecting the liver, kidneys, or neurological system may happen in 10% of patients. Leptospirosis can be treated by a doctor prescribing particular antibiotics. Those who have this disease must get treated as soon as possible.

Market Dynamics

Increasing research and development activities focused on vaccine development for the treatment of leptospirosis by research institutes are expected to drive the global leptospirosis market's growth over the forecast period. For instance, on July 6, 2022, The Yale School of Medicine, U.S., announced the university is focused on the vaccine development indicated for the deadly Leptospirosis bacteria. The next step is to translate the laboratory discovery into vaccines, first for animals and then for humans.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global leptospirosis market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include USAntibiotics, Dr. Reddy's Laboratories Ltd., Century Pharmaceuticals Ltd., Mayne Pharma Group Limited, Sun Pharmaceutical Industries, Inc., Ralington Pharma, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sandoz International GmbH, ISKON REMEDIES & GMT, Haustus Biotech Pvt. Ltd., and Aden Healthcare
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global leptospirosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leptospirosis market

Detailed Segmentation:

• Global Leptospirosis Market, By Drug (Revenue, USD Mn, 2021 - 2033)
• Amoxicillin
• Azithromycin
• Cefixime
• Doxycycline
• Others (Ceftriaxone,Penicillin among others)
• Global Leptospirosis Market, By Diagnosis (Revenue, USD Mn, 2021 - 2033)
• Complete Blood Count (CBC)
• Creatine Kinase
• Liver Enzymes
• Urinalysis
• Others (Lumbar puncture, Microscopic agglutination test among others)
• Global Leptospirosis Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)
• Oral
• Parenteral
• Intravenous
• Global Leptospirosis Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Global Leptospirosis Market, By Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
• USAntibiotics
• Reddy's Laboratories Ltd.
• Century Pharmaceuticals Ltd.
• Mayne Pharma Group Limited
• Sun Pharmaceutical Industries, Inc.
• Ralington Pharma,
• F.Hoffmann-La Roche Ltd
• Pfizer Inc.
• Sandoz International GmbH
• ISKON REMEDIES & GMT
• Haustus Biotech Pvt. Ltd.
• Aden Healthcare

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug
  • Market Snapshot, By Diagnosis
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Regulatory Guidelines
• Product launches
• Key Development
• PEST Analysis
• Regulatory Scenario
• Mergers and Acquisitions

4. Global Leptospirosis Market, By Drug, 2021 - 2033, (US$ Million)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Amoxicillin
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Azithromycin
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Cefixime
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Doxycycline
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Others (Ceftriaxone, Penicillin among others)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Leptospirosis Market, By Diagnosis, 2021 - 2033, (US$ Million)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Complete Blood Count (CBC)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Creatine Kinase
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Liver Enzymes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Urinalysis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Others (Lumbar puncture, Microscopic agglutination test among others)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Leptospirosis Market, By Route of Administration, 2021 - 2033, (US$ Million)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Parenteral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Intravenous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

7. Global Leptospirosis Market, By Distribution Channel, 2021 - 2033, (US$ Million)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

8. Global Leptospirosis Market, By Region, 2021 - 2033, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2022-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2021 - 2033, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• USAntibiotics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Reddy's Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Century Pharmaceuticals Ltd.
  • Company Highlight
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mayne Pharma Group Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sun Pharmaceutical Industries, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Ralington Pharma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• F. Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sandoz International GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ISKON REMEDIES & GMT
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Haustus Biotech Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aden Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us